Dietary Zinc Alters the Microbiota and Decreases Resistance to Clostridium difficile Infection

Clostridium difficile is the most commonly reported nosocomial pathogen in the United States and is an urgent public health concern worldwide. Over the past decade, incidence, severity and costs associated with C. difficile infection (CDI) have increased dramatically. CDI is most commonly initiated by antibiotic-mediated disruption of the gut microbiota; however, non-antibiotic-associated CDI cases are well documented and on the rise. This suggests that unexplored environmental, nutrient and host factors probably influence CDI. Here we show that excess dietary zinc (Zn) substantially alters the gut microbiota and, in turn, reduces the minimum amount of antibiotics needed to confer susceptibility to CDI. In mice colonized with C. difficile, excess dietary Zn severely exacerbated C. difficile–associated disease by increasing toxin activity and altering the host immune response. In addition, we show that the Zn-binding S100 protein calprotectin has antimicrobial effects against C. difficile and is an essential component of the innate immune response to CDI. Taken together, these data suggest that nutrient Zn levels have a key role in determining susceptibility to CDI and severity of disease, and that calprotectin-mediated metal limitation is an important factor in the host immune response to C. difficile.

[1]  N. Sullivan,et al.  Investigation of an outbreak of antibiotic-associated colitis by various typing methods , 1982, Journal of clinical microbiology.

[2]  J. Silva,et al.  Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. , 1981, The American journal of medicine.

[3]  Patrick D Schloss,et al.  The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection , 2011, Gut microbes.

[4]  R. Knight,et al.  The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.

[5]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[6]  Lawrence A. David,et al.  Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.

[7]  N. Hogg,et al.  Myeloid Cell Function in MRP-14 (S100A9) Null Mice , 2003, Molecular and Cellular Biology.

[8]  Bo Li,et al.  Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection , 2014, Nature Communications.

[9]  E. Feuille The Antibacterial Lectin RegIII-Gamma Promotes the Spatial Segregation of Microbiota and Host in the Intestine , 2012 .

[10]  J. Drijfhout,et al.  Clostridium difficile secreted Pro‐Pro endopeptidase PPEP‐1 (ZMP1/CD2830) modulates adhesion through cleavage of the collagen binding protein CD2831 , 2015, FEBS letters.

[11]  Eric P. Skaar,et al.  The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration , 2014, PLoS pathogens.

[12]  P. Schloss,et al.  Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile , 2015, mBio.

[13]  C. Kelly,et al.  Clostridium difficile--more difficult than ever. , 2008, The New England journal of medicine.

[14]  K. Garey,et al.  Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection , 2016 .

[15]  D. Giedroc,et al.  Crystal structure of Clostridium difficile toxin A , 2016, Nature Microbiology.

[16]  G. Núñez,et al.  Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. , 2015, Immunity.

[17]  P. Higgins,et al.  Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults , 2016, Infectious diseases.

[18]  D. Serruto,et al.  Identification of a Novel Zinc Metalloprotease through a Global Analysis of Clostridium difficile Extracellular Proteins , 2013, PloS one.

[19]  W. Ludwig,et al.  SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB , 2007, Nucleic acids research.

[20]  P. Schloss,et al.  The Human Gut Microbiome as a Screening Tool for Colorectal Cancer , 2014, Cancer Prevention Research.

[21]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[22]  Structural characterization of zinc-bound Zmp1, a zinc-dependent metalloprotease secreted by Clostridium difficile , 2016, JBIC Journal of Biological Inorganic Chemistry.

[23]  Carlene A. Muto,et al.  Measures to control and prevent Clostridium difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Mark H. Wilcox,et al.  Clostridium difficile infection: new developments in epidemiology and pathogenesis , 2009, Nature Reviews Microbiology.

[25]  G. Núñez,et al.  Protective Role of Commensals against Clostridium difficile Infection via an IL-1β–Mediated Positive-Feedback Loop , 2012, The Journal of Immunology.

[26]  E. Siew,et al.  Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. , 2009, Journal of the American Society of Nephrology : JASN.

[27]  Eric P. Skaar,et al.  Identification of an Acinetobacter baumannii Zinc Acquisition System that Facilitates Resistance to Calprotectin-mediated Zinc Sequestration , 2012, PLoS pathogens.

[28]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[29]  D. R. Cutler,et al.  Utah State University From the SelectedWorks of , 2017 .

[30]  Andrew P. Martin Phylogenetic Approaches for Describing and Comparing the Diversity of Microbial Communities , 2002, Applied and Environmental Microbiology.

[31]  Eric P. Skaar,et al.  Nutritional immunity: transition metals at the pathogen–host interface , 2012, Nature Reviews Microbiology.

[32]  Jack C. Yue,et al.  A Similarity Measure Based on Species Proportions , 2005 .

[33]  Richard M. Caprioli,et al.  MntABC and MntH Contribute to Systemic Staphylococcus aureus Infection by Competing with Calprotectin for Nutrient Manganese , 2013, Infection and Immunity.

[34]  Eric P. Skaar,et al.  Nutritional Immunity: S100 Proteins at the Host-Pathogen Interface* , 2015, The Journal of Biological Chemistry.

[35]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[36]  M. Quail,et al.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium , 2009, Genome Biology.

[37]  Lisa G Winston,et al.  Burden of Clostridium difficile Infection in the United States , 2015 .

[38]  C. F. Fischer Walker,et al.  Zinc and the risk for infectious disease. , 2004, Annual review of nutrition.

[39]  A. Magurran,et al.  Temporal turnover and the maintenance of diversity in ecological assemblages , 2010, Philosophical Transactions of the Royal Society B: Biological Sciences.

[40]  D. Leffler,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[41]  Eric P. Skaar,et al.  Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. , 2011, Cell host & microbe.

[42]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[43]  Chris Sander,et al.  Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile , 2014, Nature.

[44]  D. Aronoff,et al.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains , 2011, Gut microbes.